Locus-Specific Reversible DNA Methylation Regulates Transient IL-10 Expression in Th1 Cells

Area of Science:

• Immunology
• Epigenetics
• Molecular Biology

Background:

• Interleukin-10 (IL-10) is crucial for immune homeostasis but is produced at low levels by Th1 cells.
• Epigenetic regulation of the IL-10 gene in Th1 cells remains incompletely understood.

Purpose of the Study:

• To investigate the epigenetic mechanisms controlling IL-10 gene expression in Th1 cells.
• To elucidate the role of DNA methylation and demethylation in IL-10 regulation.

Main Methods:

• Bioinformatics analysis (EMBOSS CpG plot) and bisulfite pyrosequencing to identify CpG methylation sites.
• In vitro treatment of Th1 cells with IL-12 and IL-27.
• Isolation and analysis of T cells from lymphocytic choriomeningitis virus-infected mice.
• Analysis of STAT1 and STAT3 binding to IL-10 gene locus.
• Assessment of IL-10 production in STAT1 or STAT3 knockout mice.

Main Results:

• Progressive DNA methylation at CpG sites in the IL-10 locus represses gene expression in Th1 cells.
• IL-12/IL-27 treatment or viral infection induced IL-10 production through selective DNA demethylation at intron 3 (ROI 3).
• STAT1 and STAT3 binding to demethylated ROI 3 enhanced IL-10 expression.
• STAT1 or STAT3 deficiency impaired IL-10 production in CD4+ T cells.

Conclusions:

• While promoter DNA methylation stably represses IL-10 in Th1 cells, locus-specific demethylation at ROI 3 provides a platform for transient IL-10 expression.
• Reversible epigenetic modifications control IL-10 production, influencing immune homeostasis during inflammation.